Has Christopher Kniese, MD received payments from drug or device companies?

Yes. Drug and device makers reported $44,084 in general payments to Christopher Kniese, MD across 52 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Kniese, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Kniese, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Kniese, MD

Critical Care Medicine · Indianapolis, INNPI 1962796102

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (34.5%), grants and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Intuitive Surgical at 39.0% of the total. Among critical care medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,084in general payments, 2019–2025

Across 52 payments — averaging $847.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$17K
Boston Scientific$16K
Cook Incorporated$6K
AstraZeneca$2K
Pulmonx Corporation$1K
Johnson & Johnson$525
plus $321 from 4 others

What the payments were for

Consulting fees$7,97218%
Speaking & faculty fees$9552%
Grants$15,00034%
Travel & lodging$3,1107%
Food & beverage$1,8324%
Education$15,21535%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	23	$17,189
Boston Scientific	8	$16,139
Cook Incorporated	8	$6,093
AstraZeneca	1	$2,334
Pulmonx Corporation	5	$1,484
Johnson & Johnson	2	$525
Galvanize Therapeutics, Inc	1	$136
Genentech USA, Inc.	1	$84
Covidien LP	1	$59
Cook Medical LLC	2	$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,084 in reported general payments places this provider in the 95th percentile of 158 critical care medicine providers in Indiana.

See all critical care medicine providers in Indiana →

Medicare billing

Part B allowed, 2024

$44,503

Medicare patients

171

Services billed

472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ambrisentan	12	$91,433
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	115	$91,249
Breo ElliptaFluticasone/Vilanterol	32	$26,340
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	38	$22,081
Spiriva RespimatTiotropium Bromide	13	$7,638
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	18	$2,779
Albuterol Sulfate HfaAlbuterol Sulfate	72	$2,133
Levalbuterol Tartrate HfaLevalbuterol Tartrate	12	$1,116
Ventolin HfaAlbuterol Sulfate	15	$987
Prednisone	59	$247
Azithromycin	14	$117
Montelukast Sodium	15	$69

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Indianapolis

Vrushank PatelIndianapolis$142K
Stanley NasrawayIndianapolis$34K
Ryan BoenteIndianapolis$15K
David RoeIndianapolis$7K
Mark MastrodicasaIndianapolis$4K
Bruce AckermanIndianapolis$3K
Julio NoriegaIndianapolis$3K
Nestor AnguianoIndianapolis$3K
Tanya DevnaniIndianapolis$3K
Damien PatelIndianapolis$3K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →